Dow Up 0.64% Nasdaq Up 0.68%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
41.88 0.68(1.65%) Sep 18, 4:00PM EDT
|After Hours : 41.80 Down 0.08 (0.19%) Sep 18, 7:59PM EDT
Prev Close:41.20
Open:42.10
Bid:N/A
Ask:42.10 x 200
1y Target Est:43.56
Beta:1.67
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:41.34 - 42.22
52wk Range:22.25 - 62.66
Volume:2,650,626
Avg Vol (3m):2,002,940
Market Cap:4.93B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
ISISUp 1.65%4.93B
ENZ247.18M
GILD160.13B
SRPT922.00M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.75
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback